 Neurocrine Biosciences NASDAQ:NBIX and Dyadic International NASDAQ:DYAI are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends. Institutional Insider Ownership 96.5 of Neurocrine Biosciences shares are owned by institutional investors. Comparatively, 11.7 ... 